Calretinin Interneurons are Early Targets of Extracellular Amyloid-β Pathology in PS1/AβPP Alzheimer Mice Hippocampus
Open accessThe DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
Specific neuronal networks are preferentially affected in the early stages of Alzheimer's disease (AD). The distinct subpopulations of hippocampal inhibitory GABAergic system have been shown to display differential vulnerability to neurodegeneration in AD. We have previously reported a substantial loss of SOM/NPY interneurons, whereas those expressing parvalbumin were unaltered, in the hippocampus of 6 month-old PS1/AbetaPP transgenic mice. In the present study, we now investigated the pathological changes of hippocampal calretinin (CR) interneurons in this PS1/AbetaPP model from 2 to 12 months of age. The total number of CR-immunoreactive inhibitory cells was determined by stereology in CA1 and CA2/3 subfields. Our findings show a substantial decrease (35%-45%) of CR-positive interneurons in both hippocampal subfields of PS1/AbetaPP mice at very early age (4 months) compared to age-matched control mice. This decrease was accompanied by a reduced CR mRNA content as determined by quantitative RT-PCR. However, the number of another hippocampal CR-positive population (belonging to Cajal-Retzius cells) was not affected. The selective early loss of CR-interneurons was parallel to the appearance of extracellular Abeta deposits, preferentially in CR-axonal fields, and the formation of dystrophic neurites. This specific GABAergic subpopulation plays a crucial role in the generation of synchronous rhythmic activity in hippocampus by controlling other interneurons. Therefore, early alterations of hippocampal inhibitory functionality in AD, caused by select CR-cells neurodegeneration, could result in cognitive impairments seen in initial stages of the disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, the observation of hippocampal interneuron loss in models which are almost devoid of CA1 pyramidal neuron loss, such as 3xTg or 5xFAD, might be more supportive of a link between loss of interneurons and the appearance of extracellular Aβ deposits [123].”
From Neuron Loss in Alzheimer’s Disease: Translation in Transgenic Mouse Models (2020) · cites this paper as [123]
In the citing paper
“Quantitative studies investigating interneuron populations in transgenic AD mouse models yielded more conclusive results, with most of the available studies reporting a loss of CR- and PV-positive interneurons in the hippocampal formation in AD transgenic mice [59,122,123,124,125,126].”
From Neuron Loss in Alzheimer’s Disease: Translation in Transgenic Mouse Models (2020) · cites this paper as [123]
Citations
Cites
The Mouse Brain in Stereotaxic Coordinates
Paxinos, G. (2001) · Cited by 13,437
Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide
Haass, C., & Selkoe, D. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2101 · Cited by 4,744
The mouse brain in stereotaxic coordinates
Konsman, J.-P. (2003) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(03)00088-x · Cited by 4,045 · cited 2×
“The number of neurons was quantified in every 7th section (with a distance of 280 µm between sections) through the entire antero-posterior extent of the hippocampus (between −0.94 mm anterior and 3.64 mm posterior to Bregman) according to the atlas of Franklin and Paxinos [24].”
MethodInfluentialNeuronal Diversity and Temporal Dynamics: The Unity of Hippocampal Circuit Operations
Klausberger, T., & Somogyi, P. (2008) · Science · doi:10.1126/science.1149381 · Cited by 2,050 · cited 1×
“In the hippocampus, there is a great cellular diversity of GABAergic interneurons which provide general inhibition by contacting with distinct domains of principal cells (for review, see [32]).”
BackgroundAβ Oligomers – a decade of discovery
Walsh, D. M., & Selkoe, D. J. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04426.x · Cited by 1,938 · cited 1×
“In fact, Aβ peptides are well established as the principal factors for the pathological events observed in AD [39–41] and there is compelling evidence showing that alterations in axonal transport play critical role in the pathogenesis of AD [42–45].”
BackgroundSynchronization of neuronal activity in hippocampus by individual GABAergic interneurons
Cobb, S. R., Buhl, E. H., Halasy, K., Paulsen, O., & Somogyi, P. (1995) · Nature · doi:10.1038/378075a0 · Cited by 1,498 · cited 1×
“This CR-positive GABAergic subpopulation plays a crucial role in the hippocampal activity by controlling other interneurons terminating on different dendritic and somatic compartments of principal cells [18–20].”
BackgroundThe efficiency of systematic sampling in stereology—reconsidered
GUNDERSEN, H. J. G., JENSEN, E. B. V., KIÊU, K., & NIELSEN, J. (1999) · Journal of Microscopy · doi:10.1046/j.1365-2818.1999.00457.x · Cited by 1,317 · cited 1×
“efficient of error (CE) [28] calculated using the CEs in each individual animal.”
MethodAxonopathy and Transport Deficits Early in the Pathogenesis of Alzheimer’s Disease
Stokin, G. B., Lillo, C., Falzone, T. L., Brusch, R. G., Rockenstein, E., Mount, S. L., Raman, R., Davies, P., Masliah, E., Williams, D. S., et al. (2005) · Science · doi:10.1126/science.1105681 · Cited by 1,214
West, M. J. (1999) · Trends in Neurosciences · doi:10.1016/s0166-2236(98)01362-9 · Cited by 827 · cited 1×
“thickness, and ∑ Q− is the total count of nuclei sampled for the entire layer [25–27].”
BackgroundRole of Axonal Transport in Neurodegenerative Diseases
De Vos, K. J., Grierson, A. J., Ackerley, S., & Miller, C. C. J. (2008) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.31.061307.090711 · Cited by 738 · cited 1×
“In fact, Aβ peptides are well established as the principal factors for the pathological events observed in AD [39–41] and there is compelling evidence showing that alterations in axonal transport play critical role in the pathogenesis of AD [42–45].”
BackgroundDesign-based stereology in neuroscience
Schmitz, C., & Hof, P. R. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2004.08.050 · Cited by 681 · cited 1×
“thickness, and ∑ Q− is the total count of nuclei sampled for the entire layer [25–27].”
BackgroundTissue shrinkage and unbiased stereological estimation of particle number and size*
Dorph‐Petersen, K. ‐., Nyengaard, J. R., & Gundersen, H. J. G. (2001) · Journal of Microscopy · doi:10.1046/j.1365-2818.2001.00958.x · Cited by 539 · cited 1×
“thickness, and ∑ Q− is the total count of nuclei sampled for the entire layer [25–27].”
BackgroundGulyás, A. I., Hájos, N., & Freund, T. F. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-10-03397.1996 · Cited by 512 · cited 1×
“Among these GABA interneurons, those expressing the calcium binding protein calretinin represent a small percent, about 10% [31], however, they play a crucial role regulating the activity of other GABAergic inhibitory interneurons and subsequently the excitatory action of principal cells [19].”
BackgroundSuh, Y.-H., & Checler, F. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.3.469 · Cited by 467
Changes in Ca2+-binding proteins in human neurodegenerative disorders
Heizmann, C. W., & Braun, K. (1992) · Trends in Neurosciences · doi:10.1016/0166-2236(92)90067-i · Cited by 409 · cited 1×
“The relevance of calretinin and other calcium binding proteins in neurodegenerative diseases, and particularly AD, has been supported by several studies [13,14,33–35].”
ResultPalop, J. J., Jones, B., Kekonius, L., Chin, J., Yu, G.-Q., Raber, J., Masliah, E., & Mucke, L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1133381100 · Cited by 402 · cited 1×
“The relevance of calretinin and other calcium binding proteins in neurodegenerative diseases, and particularly AD, has been supported by several studies [13,14,33–35].”
ResultIacopino, A. M., & Christakos, S. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.11.4078 · Cited by 387 · cited 1×
“The relevance of calretinin and other calcium binding proteins in neurodegenerative diseases, and particularly AD, has been supported by several studies [13,14,33–35].”
ResultJimenez, S., Baglietto-Vargas, D., Caballero, C., Moreno-Gonzalez, I., Torres, M., Sanchez-Varo, R., Ruano, D., Vizuete, M., Gutierrez, A., & Vitorica, J. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3024-08.2008 · Cited by 383 · cited 5×
“In this sense, we have described an association between extracellular Aβ and/or cytotoxic glial environment and the neurodegeneration of hippocampal principal cells [23] in layer V pyramidal cells of the entorhinal cortex in this PS1/AβPP”
BackgroundMethodSelf-citationAlzheimer disease models and human neuropathology: similarities and differences
Duyckaerts, C., Potier, M.-C., & Delatour, B. (2008) · Acta Neuropathologica · doi:10.1007/s00401-007-0312-8 · Cited by 375 · cited 1×
“sion and the mechanisms underlying neuronal dysfunction [1,2].”
BackgroundBlanchard, V., Moussaoui, S., Czech, C., Touchet, N., Bonici, B., Planche, M., Canton, T., Jedidi, I., Gohin, M., Wirths, O., et al. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(03)00252-8 · Cited by 283 · cited 2×
“5–3 months of age in this transgenic model [21].”
BackgroundChan‐Palay, V. (1987) · Journal of Comparative Neurology · doi:10.1002/cne.902600205 · Cited by 254 · cited 1×
“Moreover, both brain areas in this transgenic mice display a prominent early reduction of SOM/NPY interneurons of GABA system [3,4] as occurs in AD brains [5–12].”
BackgroundRamos, B., Baglietto-Vargas, D., Rio, J. C. D., Moreno-Gonzalez, I., Santa-Maria, C., Jimenez, S., Caballero, C., Lopez-Tellez, J. F., Khan, Z. U., Ruano, D., et al. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.09.022 · Cited by 216 · cited 9×
“Supporting these data, we have previously demonstrated an early neurodegeneration of SOM/NPY cells in this AD model [4], however, other interneuronalpopulations (such as cholecystokinin positive interneurons) could be also affected (see [37]).”
BackgroundMethodSelf-citationLiu, Y., Yoo, M.-J., Savonenko, A., Stirling, W., Price, D. L., Borchelt, D. R., Mamounas, L., Lyons, W. E., Blue, M. E., & Lee, M. K. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4218-08.2008 · Cited by 206 · cited 1×
“Supporting the direct impact of extracellular Aβ on neuronal death, Liu and colleagues [38] recently reported a relationship between forebrain extracellular Aβ accumulation and the progressive degeneration of monoaminergic afferent axons and their corresponding subcortical cell bodies.”
BackgroundCalretinin-immunoreactive neocortical interneurons are unaffected in Alzheimer's disease
Hof, P. R., Nimchinsky, E. A., Celio, M. R., Bouras, C., & Morrison, J. H. (1993) · Neuroscience Letters · doi:10.1016/0304-3940(93)90504-e · Cited by 172 · cited 1×
“Some studies have reported the resistance of CR neocortical neurons to degeneration in AD [15,16], however, a layer specific vulnerability of CR-cells associated with the presence of neurofibrillary tangles has been shown in AD neocortex [17].”
BackgroundJinno, S., & Kosaka, T. (2006) · Neuroscience Research · doi:10.1016/j.neures.2006.07.007 · Cited by 167 · cited 2×
“stratum radiatum has been reported to contain higher proportion of CR interneurons than stratum oriens [31].”
BackgroundIn vivo axonal transport rates decrease in a mouse model of Alzheimer's disease
Smith, K. D. B., Kallhoff, V., Zheng, H., & Pautler, R. G. (2007) · NeuroImage · doi:10.1016/j.neuroimage.2007.01.046 · Cited by 164 · cited 1×
“In fact, Aβ peptides are well established as the principal factors for the pathological events observed in AD [39–41] and there is compelling evidence showing that alterations in axonal transport play critical role in the pathogenesis of AD [42–45].”
BackgroundNeuropeptide Y immunoreactivity is reduced in cerebral cortex in Alzheimer's disease
Beal, M. F., Mazurek, M. F., Chattha, G. K., Svendsen, C. N., Bird, E. D., & Martin, J. B. (1986) · Annals of Neurology · doi:10.1002/ana.410200303 · Cited by 160 · cited 1×
“Moreover, both brain areas in this transgenic mice display a prominent early reduction of SOM/NPY interneurons of GABA system [3,4] as occurs in AD brains [5–12].”
BackgroundRelevance of Transgenic Mouse Models to Human Alzheimer Disease
Morrissette, D. A., Parachikova, A., Green, K. N., & LaFerla, F. M. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.r800030200 · Cited by 147 · cited 1×
“sion and the mechanisms underlying neuronal dysfunction [1,2].”
BackgroundImpaired long-term potentiation induction in dentate gyrus of calretinin-deficient mice
Schurmans, S., Schiffmann, S. N., Gurden, H., Lemaire, M., Lipp, H.-P., Schwam, V., Pochet, R., Imperato, A., Böhme, G. A., & Parmentier, M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.19.10415 · Cited by 144 · cited 1×
“This CR-positive GABAergic subpopulation plays a crucial role in the hippocampal activity by controlling other interneurons terminating on different dendritic and somatic compartments of principal cells [18–20].”
BackgroundMikkonen, M., Alafuzoff, I. I., Tapiola, T., Soininen, H. S., & Miettinen, R. A. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00047-0 · Cited by 115 · cited 2×
“Briefly, the density of calretinin (CR) neurons, as well as the dendritic immunostaining, was reduced in the entorhinal cortex of severe AD cases [14].”
BackgroundBeal, M. F., Mazurek, M. F., Svendsen, C. N., Bird, E. D., & Martin, J. B. (1986) · Annals of Neurology · doi:10.1002/ana.410200408 · Cited by 108 · cited 1×
“Moreover, both brain areas in this transgenic mice display a prominent early reduction of SOM/NPY interneurons of GABA system [3,4] as occurs in AD brains [5–12].”
BackgroundAcsády, L., Halasy, K., & Freund, T. F. (1993) · Neuroscience · doi:10.1016/0306-4522(93)90532-k · Cited by 99 · cited 1×
“These interneurons receive afferents from the GABAergic component of the septohippocampal pathway and from serotoninergic raphe neurons [46].”
BackgroundReelin‐expressing neurons in the postnatal and adult human hippocampal formation
Abraham, H., & Meyer, G. (2003) · Hippocampus · doi:10.1002/hipo.10125 · Cited by 94 · cited 1×
“These CR-cells corresponded to Cajal-Retzius neurons which coexpress reelin [30] (Fig.”
BackgroundGrouselle, D., Winsky-Sommerer, R., David, J. P., Delacourte, A., Dournaud, P., & Epelbaum, J. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00698-3 · Cited by 92
Calretinin-immunoreactive neurons in the normal human temporal cortex and in Alzheimer's disease
Fonseca, M., & Soriano, E. (1995) · Brain Research · doi:10.1016/0006-8993(95)00622-w · Cited by 89 · cited 1×
“Some studies have reported the resistance of CR neocortical neurons to degeneration in AD [15,16], however, a layer specific vulnerability of CR-cells associated with the presence of neurofibrillary tangles has been shown in AD neocortex [17].”
BackgroundNakamura, S., & Vincent, S. R. (1986) · Brain Research · doi:10.1016/0006-8993(86)91099-1 · Cited by 80 · cited 1×
“Moreover, both brain areas in this transgenic mice display a prominent early reduction of SOM/NPY interneurons of GABA system [3,4] as occurs in AD brains [5–12].”
BackgroundSampson, V. L., Morrison, J. H., & Vickers, J. C. (1997) · Experimental Neurology · doi:10.1006/exnr.1997.6433 · Cited by 75 · cited 1×
“Some studies have reported the resistance of CR neocortical neurons to degeneration in AD [15,16], however, a layer specific vulnerability of CR-cells associated with the presence of neurofibrillary tangles has been shown in AD neocortex [17].”
BackgroundMátyás, F., Freund, T. F., & Gulyás, A. I. (2004) · Hippocampus · doi:10.1002/hipo.10191 · Cited by 75 · cited 1×
“The immunohistochemical examination of WT sections revealed CR-positive cells in all layers (more often in principal cell layer) of CA1 regions with multipolar and bipolar or fusiform somata as previously described [29].”
Neuropeptide Abnormalities in Patients With Early Alzheimer Disease
Davis, K. L., Mohs, R. C., Marin, D. B., Purohit, D. P., Perl, D. P., Lantz, M., Austin, G., & Haroutunian, V. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.11.981 · Cited by 72 · cited 1×
“Moreover, both brain areas in this transgenic mice display a prominent early reduction of SOM/NPY interneurons of GABA system [3,4] as occurs in AD brains [5–12].”
BackgroundGaspar, P., Duyckaerts, C. J., Febvret, A., Benoit, R., Beck, B., & Berger, B. (1989) · Brain Research · doi:10.1016/0006-8993(89)90424-1 · Cited by 70 · cited 1×
“Moreover, both brain areas in this transgenic mice display a prominent early reduction of SOM/NPY interneurons of GABA system [3,4] as occurs in AD brains [5–12].”
BackgroundA subset of calretinin-positive neurons are abnormal in Alzheimer's disease
Brion, J., & R�sibois, A. (1994) · Acta Neuropathologica · doi:10.1007/bf00294357 · Cited by 65
Cholecystokinin and somatostatin in Alzheimer's disease postmortem cerebral cortex
Mazurek, M. F., & Beal, F. M. (1991) · Neurology · doi:10.1212/wnl.41.5.716 · Cited by 58 · cited 1×
“Supporting these data, we have previously demonstrated an early neurodegeneration of SOM/NPY cells in this AD model [4], however, other interneuronalpopulations (such as cholecystokinin positive interneurons) could be also affected (see [37]).”
Moreno-Gonzalez, I., Baglietto-Vargas, D., Sanchez-Varo, R., Jimenez, S., Trujillo-Estrada, L., Sanchez-Mejias, E., del Rio, J. C., Torres, M., Romero-Acebal, M., Ruano, D., et al. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-1192 · Cited by 42
Self-citationPopović, M., Caballero-Bleda, M., Kadish, I., & Van Groen, T. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.05.023 · Cited by 38 · cited 1×
“Supporting the existence of altered CR networks in AD pathology, Popovic and colleagues [36] have recently reported decreased CR-immunoreactivity in the dentate gyrus hilar cells (mostly excitatory mossy cells) of another AD model.”
BackgroundSomatostatin-281–12-like immunoreactivity is reduced in Alzheimer's disease cerebral cortex
Beal, M. F., Benoit, R., Mazurek, M. F., Bird, E. D., & Martin, J. B. (1986) · Brain Research · doi:10.1016/0006-8993(86)90586-x · Cited by 32
Alzheimer's disease: an intracellular movement disorder?
Zhu, X., Moreira, P. I., Smith, M. A., & Perry, G. L. (2005) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2005.07.002 · Cited by 20 · cited 1×
“In fact, Aβ peptides are well established as the principal factors for the pathological events observed in AD [39–41] and there is compelling evidence showing that alterations in axonal transport play critical role in the pathogenesis of AD [42–45].”
BackgroundCaballero, C., Jiménez, S., Moreno‐González, I., Baglietto‐Vargas, D., Sanchez-Varo, R. M., Gavilán, M. P., Ramos, B., del Río, J. C., Vizuete, M., Gutiérrez, A., et al. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21172 · Cited by 9
Self-citationMátyás, F., Freund, T. F., & Gulyás, A. I. (2004) · Hippocampus · doi:10.1002/hipo.100191 · Cited by 5
Cited by
Hippocampal GABAergic Inhibitory Interneurons
Pelkey, K. A., Chittajallu, R., Craig, M. T., Tricoire, L., Wester, J. C., & McBain, C. J. (2017) · Physiological Reviews · doi:10.1152/physrev.00007.2017 · Cited by 889
Epileptic activity in Alzheimer’s disease: Causes and clinical relevance
Vossel, K. A., Tartaglia, M. C., Nygaard, H. B., Zeman, A. Z., & Miller, B. L. (2017) · The Lancet Neurology · doi:10.1016/s1474-4422(17)30044-3 · Cited by 590
Modifiable Risk Factors for Alzheimer’s Disease
Edwards III, G. A., Gamez, N., Escobedo Jr., G., Calderon, O., & Moreno-Gonzalez, I. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00146 · Cited by 253
“APP/PS1 mice have early-impaired GABAergic interneurons in the hippocampus and entorhinal cortex (Ramos et al., 2006; Moreno-Gonzalez et al., 2009; Baglietto-Vargas et al., 2010).”
BackgroundSanchez-Varo, R., Trujillo-Estrada, L., Sanchez-Mejias, E., Torres, M., Baglietto-Vargas, D., Moreno-Gonzalez, I., De Castro, V., Jimenez, S., Ruano, D., Vizuete, M., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-011-0896-x · Cited by 222
Self-citationPhagocytic clearance of presynaptic dystrophies by reactive astrocytes in Alzheimer's disease
Gomez‐Arboledas, A., Davila, J. C., Sanchez‐Mejias, E., Navarro, V., Nuñez‐Diaz, C., Sanchez‐Varo, R., Sanchez‐Mico, M. V., Trujillo‐Estrada, L., Fernandez‐Valenzuela, J. J., Vizuete, M., et al. (2018) · Glia · doi:10.1002/glia.23270 · Cited by 220
“We have previously characterized this APP/PS1 transgenic model (Baglietto-Vargas et al., 2010; Jimenez et al., 2008; Ramos et al., 2006; Sanchez-Varo et al., 2012; Torres et al., 2012; Trujillo-Estrada et al., 2014).”
BackgroundSelf-citation
Metadata
- Authors
- Baglietto-Vargas, D., Moreno-Gonzalez, I., Sanchez-Varo, R., Jimenez, S., Trujillo-Estrada, L., Sanchez-Mejias, E., Torres, M., Romero-Acebal, M., Ruano, D., Vizuete, M., Vitorica, J., & Gutierrez, A.
- Affiliations
- Dpto. Biología Celular, Genética y Fisiología, Facultad de Ciencias, Universidad de Málaga, Spain
- Biomedical Research Networking Center on Neurodegenerative Diseases (ES)
- Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Spain
- Venue
- Journal of Alzheimer's Disease
- Publisher
- SAGE Publications
- Published
- 2010-07-08
- Volume
- 21
- Issue
- 1
- Pages
- 119-132
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- OpenAlex
- W1545362509
- Cited by
- 98
- References
- 48
- Citations by year
- 2026: 4 · 2025: 3 · 2024: 11 · 2023: 2 · 2022: 4 · 2021: 3 · 2020: 7 · 2019: 10 · 2018: 3 · 2017: 5 · 2016: 9 · 2015: 7 · 2014: 9 · 2013: 8 · 2012: 6
- FWCI
- 4.30
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Alzheimer s Disease (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Repositorio Institucional de la Universidad de Málaga (University of Málaga) (submittedVersion, cc-by)
- Funders
- Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas
- Instituto de Salud Carlos III
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- calretinin interneurons, Alzheimer's disease
- MeSH terms
- Age Factors, Alzheimer Disease, Analysis of Variance, Animals, Disease Models, Animal, Gene Expression Regulation, Hippocampus, Humans, Interneurons, Mice, Inbred C57BL, Mice, Transgenic, Phosphopyruvate Hydratase, Amyloid beta-Peptides, Amyloid beta-Protein Precursor, Mice, Presenilin-1, S100 Calcium Binding Protein G, Calbindin 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.